International Flavors & Fragrances Inc. (IFF) 股票分析

公司概述

International Flavors & Fragrances Inc. manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products across the United States and international markets. The company operates within the Basic Materials sector, specifically the Specialty Chemicals industry, which characterizes its role as a provider of essential chemical inputs for consumer and industrial applications. As of the latest data, the entity holds a market capitalization of $18.68B, reports annual revenue of $10.89B, and employs 21,500 individuals. These valuation and operational figures indicate that the company maintains a substantial market presence and possesses significant scale within the global flavors and fragrances supply chain.

财务健康

The company reported revenue of $10.89B for the trailing twelve months, yet recorded a net income of $-361,000,000 and an EBITDA of $1.86B. The substantial gap between the positive EBITDA of $1.86B and the negative net income reveals a heavy tax or interest burden that significantly impacts the bottom line despite underlying operational profitability. Operating cash generation remains robust with free cash flow reaching $3.09B, which provides the company with considerable financial flexibility to fund operations or return capital. The gross margin stands at 36.2%, while the operating margin is 4.6% and the profit margin is -3.3%; these figures suggest that while production costs are relatively contained, the final profitability is eroded by non-operating expenses or taxes. On the balance sheet, cash holdings of $590.00M contrast sharply with total debt of $6.65B, resulting in a debt-to-equity ratio of 46.88, indicating a leveraged capital structure. The current ratio of 1.42 suggests adequate short-term liquidity to meet obligations as they come due. Return on equity is recorded at -2.6% and return on assets at 2.1%, metrics that highlight management's current inability to generate equity returns while still maintaining positive asset utilization.

估值评估

The valuation metrics show a forward P/E of 15.23, whereas the trailing P/E is listed as N/A due to the negative net income. The absence of a trailing P/E relative to the forward metric implies that the market is pricing in future earnings recovery rather than valuing current profitability. The price-to-book ratio is 1.32, which indicates that the stock trades at a slight premium over its book value despite recent earnings volatility. Alternative valuation measures include a price-to-sales ratio of 1.72 and an EV/EBITDA of 13.34, suggesting the market values the firm based on its cash-flow generation capabilities rather than accounting earnings. The stock has a 52-week high of $84.45 and a 52-week low of $59.14, and while the exact current price is not explicitly provided in the source data, the forward P/E implies the market is looking ahead to potential price stabilization. The beta value is 1.03, meaning the stock exhibits price volatility that is slightly higher than the broader market benchmark.

Growth & Income

Revenue growth year-over-year is -6.6%, while earnings growth is N/A due to the negative net income period. Since earnings are not growing while revenue is contracting, this implies a deterioration in profitability efficiency relative to sales volume during the reporting period. For dividend payers, the company offers a dividend yield of 2.2%, but the payout ratio is 168.4%. This extremely high payout ratio indicates that dividends are being funded primarily from cash reserves or capital rather than current earnings, raising questions about sustainability given the negative net income. The overall growth and income profile currently reflects a period of financial contraction where income generation is lagging, yet the company maintains a significant free cash flow position that supports its dividend obligations.